Literature DB >> 20963400

The relationship of fetuin-A and lactoferrin with bone mass in elderly women.

L Chailurkit1, A Kruavit, R Rajatanavin, B Ongphiphadhanakul.   

Abstract

SUMMARY: The relationships of fetuin-A and lactoferrin to bone-related phenotypes were investigated in elderly women. Fetuin-A was associated not only with bone mineral density (BMD) but also with bone resorption marker suggesting an influence of fetuin-A on osteoclasts.
INTRODUCTION: The aim of this study is to investigate the relationship of bone-related phenotypes in elderly women with circulating fetuin-A and lactoferrin.
METHODS: Eighty-two elderly women were studied. Serum fetuin-A, lactoferrin, C-terminal telopeptide of type I collagen (CTx), total procollagen type 1 amino-terminal propeptide, and plasma intact parathyroid hormone (PTH) were analyzed. BMD of the lumbar spine at L2-4 and at the femoral neck was measured.
RESULTS: Serum fetuin-A was significantly associated with L2-4 BMD (r = 0.23, P < 0.05). After controlling for age and body weight, the association remained statistically significant. There was a significant association between serum fetuin-A and serum CTx (r = -0.37, P < 0.001). The association between fetuin-A and L2-4 BMD no longer existed after controlling for serum CTx. There were positive associations of circulating lactoferrin with plasma PTH (r = 0.24, P < 0.05) and serum CTx (r = 0.26, P < 0.05). No association between serum lactoferrin and BMD at the lumbar spine or femoral neck was detected.
CONCLUSIONS: Circulating fetuin-A is related to bone mass and bone resorption markers in elderly women. Lactoferrin, in contrast, is associated only with bone resorption markers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20963400     DOI: 10.1007/s00198-010-1439-3

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  16 in total

1.  Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity.

Authors:  Florence Lorget; Jennifer Clough; Manuel Oliveira; Marc-Cedric Daury; Afsie Sabokbar; Elizabeth Offord
Journal:  Biochem Biophys Res Commun       Date:  2002-08-16       Impact factor: 3.575

2.  Mineralization by inhibitor exclusion: the calcification of collagen with fetuin.

Authors:  Paul A Price; Damon Toroian; Joo Eun Lim
Journal:  J Biol Chem       Date:  2009-05-04       Impact factor: 5.157

Review 3.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

4.  Fetuin-A expression in early venous stenosis formation in a porcine model of hemodialysis graft failure.

Authors:  Sanjay Misra; Alex A Fu; Jill L Anderson; James F Glockner; Michael A McKusick; Haraldur Bjarnason; David A Woodrum; Debabrata Mukhopadhyay
Journal:  J Vasc Interv Radiol       Date:  2008-08-09       Impact factor: 3.464

5.  Fetuin-A and BMD in older persons: the Health Aging and Body Composition (Health ABC) study.

Authors:  Joachim H Ix; Christina L Wassel; Douglas C Bauer; Damon Toroian; Frances A Tylavsky; Jane A Cauley; Tamara B Harris; Paul A Price; Steven R Cummings; Michael G Shlipak
Journal:  J Bone Miner Res       Date:  2009-03       Impact factor: 6.741

6.  Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss.

Authors:  Thomas Reinehr; Christian L Roth
Journal:  J Clin Endocrinol Metab       Date:  2008-08-26       Impact factor: 5.958

7.  Immunohistochemical localization and mRNA expression of matrix Gla protein and fetuin-A in bone biopsies of hemodialysis patients.

Authors:  Giorgio Coen; Paola Ballanti; Giuliana Silvestrini; Daniela Mantella; Micaela Manni; Salvatore Di Giulio; Stefania Pisanò; Martina Leopizzi; Giuseppe Di Lullo; Ermanno Bonucci
Journal:  Virchows Arch       Date:  2009-01-17       Impact factor: 4.064

8.  Oral bovine lactoferrin improves bone status of ovariectomized mice.

Authors:  Anne Blais; Arnaud Malet; Takashi Mikogami; Christine Martin-Rouas; Daniel Tomé
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-03-31       Impact factor: 4.310

9.  Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.

Authors:  Cornelia Weikert; Norbert Stefan; Matthias B Schulze; Tobias Pischon; Klaus Berger; Hans-Georg Joost; Hans-Ulrich Häring; Heiner Boeing; Andreas Fritsche
Journal:  Circulation       Date:  2008-11-24       Impact factor: 29.690

10.  Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo.

Authors:  Jillian Cornish; Karen E Callon; Dorit Naot; Kate P Palmano; Tatjana Banovic; Usha Bava; Maureen Watson; Jian-Ming Lin; P C Tong; Qi Chen; Vincent A Chan; Helen E Reid; Nick Fazzalari; Heather M Baker; Edward N Baker; Neill W Haggarty; Andrew B Grey; Ian R Reid
Journal:  Endocrinology       Date:  2004-05-27       Impact factor: 4.736

View more
  6 in total

Review 1.  The role of fetuin-A in mineral trafficking and deposition.

Authors:  Michael M X Cai; Edward R Smith; Stephen G Holt
Journal:  Bonekey Rep       Date:  2015-05-06

Review 2.  Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus.

Authors:  Sazan Rasul; Ludwig Wagner; Alexandra Kautzky-Willer
Journal:  Endocrine       Date:  2012-07-21       Impact factor: 3.633

3.  Causal relationship between the AHSG gene and BMD through fetuin-A and BMI: multiple mediation analysis.

Authors:  C Sritara; A Thakkinstian; B Ongphiphadhanakul; L Chailurkit; S Chanprasertyothin; W Ratanachaiwong; P Vathesatogkit; P Sritara
Journal:  Osteoporos Int       Date:  2014-02-26       Impact factor: 4.507

4.  Relationship of vitamin D status and bone mass according to vitamin D-binding protein genotypes.

Authors:  Hataikarn Nimitphong; Chanika Sritara; La-Or Chailurkit; Suwannee Chanprasertyothin; Wipa Ratanachaiwong; Piyamitr Sritara; Boonsong Ongphiphadhanakul
Journal:  Nutr J       Date:  2015-03-24       Impact factor: 3.271

Review 5.  Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis.

Authors:  Rafał Filip; Radosław P Radzki; Marek Bieńko
Journal:  Clin Interv Aging       Date:  2018-10-04       Impact factor: 4.458

6.  Serum Proteomic Analysis Reveals Vitamin D-Binding Protein (VDBP) as a Potential Biomarker for Low Bone Mineral Density in Mexican Postmenopausal Women.

Authors:  Mayeli M Martínez-Aguilar; Diana I Aparicio-Bautista; Eric G Ramírez-Salazar; Juan P Reyes-Grajeda; Aldo H De la Cruz-Montoya; Bárbara Antuna-Puente; Alberto Hidalgo-Bravo; Berenice Rivera-Paredez; Paula Ramírez-Palacios; Manuel Quiterio; Margarita Valdés-Flores; Jorge Salmerón; Rafael Velázquez-Cruz
Journal:  Nutrients       Date:  2019-11-21       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.